Group 1 - The core point of the article is that China National Pharmaceutical Group Modern has received approval from the National Medical Products Administration for the marketing application of the raw material drug ketamine hydrochloride [1] Group 2 - The approval was granted to the wholly-owned subsidiary of the company, China National Pharmaceutical Group Industrial Co., Ltd. [1] - The announcement was made on the evening of August 7 [1]